Giusti, Massimo <br/><br/>
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma.  [electronic resource] 

 -  Hormones (Athens, Greece)   
 - 304-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1109-3099 
<br/><br/><label>Standard No.: </label>10.14310/horm.2002.1111026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aging<br/>Calcium--urine<br/>Creatinine--urine<br/>Female<br/>Humans<br/>Hydroxyproline--urine<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Middle Aged<br/>Osteoporosis--physiopathology<br/>Osteoprotegerin--blood<br/>Postmenopause<br/>Premenopause<br/>RANK Ligand--blood<br/>Recombinant Proteins--administration & dosage<br/>Thyroid Neoplasms--blood<br/>Thyroidectomy<br/>Thyrotropin--administration & dosage<br/>Thyroxine--administration & dosage